LOGO
LOGO

Will Intellia Therapeutics' Upcoming Key Milestones Spark Investor Interest?

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Intellia Therapeutics Inc. (NTLA), a clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, has several upcoming key clinical program milestones to watch in the coming months.

CRISPR, which stands for "clustered interspaced short palindromic repeats", is a technology used to edit genes.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19